A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
Public ClinicalTrials.gov record NCT05330325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® as Well as Evaluating Long-term Safety of Somapacitan in a Basket Study Design in Children With Short Stature Either Born Small for Gestational Age or With Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study compares two medicines for treatment of children born small and who stay small, or with Turner Syndrome, Noonan Syndrome, or idiopathic short stature. The purpose of the study is to see how well treatment with somapacitan works compared to treatment with Norditropin®. Somapacitan is a new medicine, and Norditropin® is a medicine doctors can already prescribe in some countries. The study will last for upto 5.5 years. The participants will either get somapacitan once a week up to 5.5 years or Norditropin® once a day for 1 year followed by somapacitan once a week for up to 4.5 years. Which treatment the participants get is decided by chance.
Study identification
- NCT ID
- NCT05330325
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 412 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 10 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 10, 2022 (Actual)
- Primary completion
- Aug 5, 2024 (Actual)
- Completion
- Oct 29, 2027 (Estimated)
- Last update posted
- Jun 12, 2026
2022 – 2027
United States locations
- U.S. sites
- 35
- U.S. states
- 24
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of AL at Birmingham_BRM | Birmingham | Alabama | 35233 | — |
| Children's Hospital Los Angeles - Endocrinology | Los Angeles | California | 90027 | — |
| Sutter Valley Med Fdt Ped Endo | Sacramento | California | 95821 | — |
| Rady Childrens Hosp San Diego | San Diego | California | 92123 | — |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | — |
| Rocky Mt Ped and Endo | Centennial | Colorado | 80112 | — |
| Ped Endo Assoc PC-G.V | Greenwood Village | Colorado | 80111-2803 | — |
| Nemours/AI duPont Hosp-Chld | Wilmington | Delaware | 19803 | — |
| Childrens National Medical Ctr | Washington D.C. | District of Columbia | 20010-2978 | — |
| Nemours Chld Clnc Jacksonville | Jacksonville | Florida | 32207 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30318 | — |
| St. Luke's Children's Endo | Boise | Idaho | 83712 | — |
| Rocky Mt Clin Res, LLC | Idaho Falls | Idaho | 83404-7596 | — |
| Riley Hosp for Child-Indiana U | Indianapolis | Indiana | 46202 | — |
| University OF Iowa | Iowa City | Iowa | 52242 | — |
| UMass Medical School | Worcester | Massachusetts | 01655 | — |
| Univ of Minnesota M.C.H. | Minneapolis | Minnesota | 55454 | — |
| Children's Minnesota | Saint Paul | Minnesota | 55102 | — |
| Univ of Mississippi Med Ctr | Jackson | Mississippi | 39216 | — |
| The Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| Goryeb Children's Hospital | Morristown | New Jersey | 07962 | — |
| UBMD Peds-Div of Endo/Diabetes | Buffalo | New York | 14203 | — |
| NYU Langone Hospital-LI | Garden City | New York | 11530 | — |
| NYU Langone Hospital-LI | Mineola | New York | 11501 | — |
| WakeMed Childn Endo-Dbt_Raleig | Raleigh | North Carolina | 27610 | — |
| Akron Children's Hospital | Akron | Ohio | 44308 | — |
| CCHMC_Cinc | Cincinnati | Ohio | 45229 | — |
| Univ Oklahoma Sci Ctr OK City | Oklahoma City | Oklahoma | 73104 | — |
| UPMC Child Hosp-Pittsburgh | Pittsburgh | Pennsylvania | 15224 | — |
| UT Southwestern Med Cntr | Dallas | Texas | 75235 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
| University Of Virginia Hospital | Charlottesville | Virginia | 22903 | — |
| MultiCare Inst for Res & Innov | Tacoma | Washington | 98405 | — |
| Marshfield Clinic | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 164 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05330325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05330325 live on ClinicalTrials.gov.